Loading clinical trials...
Loading clinical trials...
This study will evaluate the efficacy and safety of two dosing regimens of a compound known as TRU-015 in combination with methotrexate (MTX) in patients with active rheumatoid arthritis.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Pfizer
Collaborators
NCT05961592 · Arthritis, Rheumatoid
NCT07017686 · Arthritis, Rheumatoid
NCT05038553 · Arthritis, Rheumatoid, Pain
NCT05790356 · Arthritis, Arthritis, Rheumatoid, and more
NCT05657847 · Arthritis, Rheumatoid, Arthritis, Psoriatic, and more
Pfizer Investigational Site
Birmingham, Alabama
Pfizer Investigational Site
Paradise Valley, Arizona
Pfizer Investigational Site
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions